Search This Blog

Wednesday, July 31, 2019

ACADIA Pharma EPS beats by $0.08, beats on revenue

ACADIA Pharma (NASDAQ:ACAD): Q2 GAAP EPS of -$0.38 beats by $0.08.
Revenue of $83.21M (+45.8% Y/Y) beats by $10.71M.
Shares +1.7%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)